Home/ Supplements/ Omega 3/ Biomega-3

Biomega-3

product on market Capsule Biotics Research Corporation Safety: 100/100
100/100

This product looks safe

  • No ingredients exceed tolerable upper intake levels
  • 33% of ingredients have research evidence
A Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Omega-3 fatty acids are supported by strong evidence for cardiovascular and inflammatory health, while Vitamin E acts as an antioxidant to protect lipids from oxidation. The evidence coverage for this specific profile is limited. With a safety score of 100, the formulation is considered well-tolerated.

AI-generated summary based on research evidence. Not medical advice.

Label

Product Label

Label for Biomega-3
Open Full PDF View on NIH DSLD →
Details

Label Data

1 Capsule(s)
Serving Size
Fat/Fatty Acid
Product Type
33%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

Calories
10 {Calories}
Total Fat
1 g (2% DV)
Cholesterol
5 mg (2% DV)
10 IU (33% DV)
Within RDA (0.4× RDA) 179 studies (A:3, B:90)
Market median: 750.0mg (447 products) 393 studies (A:18, B:204)
Marine Lipid Concentrate
1000 mg

Other Ingredients

Gelatin Glycerin Water
Claims

Label Claims — Verification

Unverified Nutrient
Unverified All Other
Info

Product Information

Directions for Use

RECOMMENDATION: One (1) capsule with each meal as a dietary supplement or as otherwise directed by a healthcare professional.

Warnings & Precautions

KEEP OUT OF REACH OF CHILDREN

Formulation Notes

Dietary Supplement with Essential Fatty Acids

Contains ingredients derived from Anchovy and Sardines.

Additional Information

Store in a cool, dry area.

Sealed with an imprinted safety seal for your protection.

Rev. 9/09

Metadata

Product Details

DSLD Entry Date2013-05-24
Product TypeFat/Fatty Acid
FormCapsule
DSLD ID21444
Data Updated2026-04-11
Research

Research Evidence

495
Research Sources
56
Avg Quality
222
Meta Analysis
104
Clinical Trial
72
Rct
69
Systematic Review
11
Guideline
5
Cochrane Review
5
Regulatory Source
3
Narrative Review
1
Openfda Safety
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2020 PubMed DOI
A Omega-3 fatty acid addition during pregnancy
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Omega-3 fatty acids for depression in adults
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
A Omega-3 fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Non-immunosuppressive treatment for IgA nephropathy
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Omega-3 fatty acid supplementation for depression in children and adolescents
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Interventions for fatigue and weight loss in adults with advanced progressive illness
Meta Analysis The Cochrane database of systematic reviews 2012 PubMed DOI
A Motor control exercise for chronic non-specific low-back pain
Meta Analysis The Cochrane database of systematic reviews 2016 PubMed DOI
A Polyunsaturated fatty acids for the primary and secondary prevention of cardiovascular disease
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
View all evidence for Omega 3 →
Compare

Similar Products

View all Omega 3 products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.